$1.97
-0.0700 (-3.43%)
At Close: Jun 03, 2026
TherapeuticsMD to Report Fourth Quarter 2021 Financial Results on March 10, 2022
09:30pm, Tuesday, 01'st Mar 2022 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced that it will report its fourth quarter 2021 financial results on Thursday, March 10, 2022, before the opening of the U.S. financial markets. Executive management will host a conference call and webcast to discuss the results and provide a business update as follows: Date: Thursday, March 10, 2022 Time: 8:30 a.m. ET Telephone Access
TherapeuticsMD to Report Fourth Quarter 2021 Financial Results on March 10, 2022
04:30pm, Tuesday, 01'st Mar 2022
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced that it will report its fou
TherapeuticsMD Inc. (TXMD) Recovers 21.89% From Low: Are We There Yet?
08:00pm, Friday, 25'th Feb 2022 Stocks Register
TherapeuticsMD Inc. (NASDAQ:TXMD) at last check was buoying at $0.22 on Friday, February 25, with a rise of 7.34% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.20 and 5Y monthly beta was reading 1.75 with its price kept floating in … TherapeuticsMD Inc. (TXMD) Recovers 21.89% From Low: Are We There Yet? Read More »
TherapeuticsMD Inc. (NASDAQ:TXMD) Stock Could Be Worth Considering
07:00pm, Friday, 11'th Feb 2022 Stocks Register
TherapeuticsMD Inc. (NASDAQ:TXMD) price on Friday, February 11, rose 1.20% below its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.26. A look at the stock’s price movement, the level at last check in today’s session was $0.26, moving within a range at $0.2585 and $0.2789. The beta value … TherapeuticsMD Inc. (NASDAQ:TXMD) Stock Could Be Worth Considering Read More »
TherapeuticsMD Inc. (NASDAQ: TXMD) Has Not A Good News: Stock Could Fall Even -1823.08%
07:00pm, Tuesday, 08'th Feb 2022 Stocks Register
TherapeuticsMD Inc. (NASDAQ:TXMD) price is hovering lower on Tuesday, February 08, dropping -2.58% below its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy
TherapeuticsMD Inc. (NASDAQ: TXMD): The Stock For Success Over The Next Few Months
12:00pm, Tuesday, 08'th Feb 2022 Marketing Sentinel
In the last trading session, 4.48 million TherapeuticsMD Inc. (NASDAQ:TXMD) shares changed hands as the company’s beta touched 1.75. With the company’s per share price at $0.27 changed hands at $0.0 or -0.81% during last session, the market valuation stood at $109.64M. TXMD’s last price was a discount, traded about -918.52% off its 52-week high … TherapeuticsMD Inc. (NASDAQ: TXMD): The Stock For Success Over The Next Few Months Read More »
3 Penny Stocks To Watch Under $1 That Are Moving Right Now
01:34pm, Tuesday, 04'th Jan 2022
Looking for penny stocks to buy under $1? Check these three out for your watchlist The post 3 Penny Stocks To Watch Under $1 That Are Moving Right Now appeared first on Penny Stocks to Buy, Picks, New
FDA Approves TherapeuticsMD's Low Dose Bijuva
06:20am, Tuesday, 04'th Jan 2022
TherapeuticsMD Inc (NASDAQ: TXMD) is trading sharply higher after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women with vasomotor symptoms due
A Bull Market Continues To Unfold On TherapeuticsMD Inc. (NASDAQ: TXMD), As It Continued To Fall -66.97% In Year-To-Date
04:30pm, Friday, 17'th Dec 2021 Marketing Sentinel
During the last session, TherapeuticsMD Inc. (NASDAQ:TXMD)’s traded shares were 3.31 million, with the beta value of the company hitting 1.82. At the end of the trading day, the stock’s price was $0.40, reflecting an intraday loss of -1.60% or -$0.01. The 52-week high for the TXMD share is $2.75, that puts it down -587.5 … A Bull Market Continues To Unfold On TherapeuticsMD Inc. (NASDAQ: TXMD), As It Continued To Fall -66.97% In Year-To-Date Read More »
TherapeuticsMD's Birth Control Med Receives FDA Response Letter To Revise Manufacturing Testing Limits
06:08am, Monday, 13'th Dec 2021
TherapeuticsMD Inc (NASDAQ: TXMD) said that the FDA could not approve revisions to certain manufacturing testing limits for Annovera through the supplemental marketing application previously submit
TherapeuticsMD says FDA rejected production updates for birth control ring
10:00pm, Friday, 10'th Dec 2021 Seeking AlphaU.S. Food and Drug Administration (FDA) Responds to Request From TherapeuticsMD to Revise Certain Manufacturing Testing Limits for ANNOVERA®
09:30pm, Friday, 10'th Dec 2021 Business Wire
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ:TXMD) (“TXMD” or the “Company”), an innovative, leading women’s healthcare company, today announced that the FDA determined that it could not approve revisions to certain manufacturing testing limits for ANNOVERA through the sNDA previously submitted by the Company. In its complete response letter, the FDA provided recommendations and requested additional information that could support approval of revisions to certain manufacturing
Little Secrets Of: TherapeuticsMD, Inc. (NASDAQ:TXMD 0.82%), Chewy, Inc. (NYSE:CHWY -6.32%)
11:51pm, Thursday, 09'th Dec 2021 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Little Secrets Of: TherapeuticsMD, Inc. (NASDAQ:TXMD 0.82%), Chewy, Inc. (NYSE:CHWY -6.32%) appeared first on Stocks Equity .
TherapeuticsMD Stock (TXMD): Why The Price Increased Today
09:15am, Thursday, 09'th Dec 2021
The stock price of TherapeuticsMD, Inc. (NASDAQ: TXMD) increased by over 3% pre-market today. This is why it happened.
Sign In
Buy TXMD